| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2009 | CN101401811A Budesonide R capsule type inhalation dust cloud agent and preparation method thereof |
| 04/08/2009 | CN101401810A Dispersible tablet containing Cefixime and preparation method thereof |
| 04/08/2009 | CN101401809A Preparation for composition of vitamin and mineral matter |
| 04/08/2009 | CN101401808A Application of scopoletin in preparing medicament for treating or preventing tumour |
| 04/08/2009 | CN101401807A Uses of selective JAK3 restrainer VI in antiviral mediated acute lung damnification |
| 04/08/2009 | CN101401806A Uses of sugar apple lactone monomeric compound in preparing medicament for treating lung cancer, mammary cancer or liver cancer |
| 04/08/2009 | CN101401805A Vitamin E supplementation to tetanus toxoid |
| 04/08/2009 | CN101401804A Uses of salvianolic acid B in preparing medicament formulation for preventing and controlling osteoporosis |
| 04/08/2009 | CN101401803A Uses of 2,5-dewatering-D-glucitol and the like in preparing cancer treatment medicament |
| 04/08/2009 | CN101401802A Medicine for treating brain apoplexy |
| 04/08/2009 | CN101401801A Curcumin glutin microsphere and preparation thereof |
| 04/08/2009 | CN101401800A Gamma-ethyl linolenate soft capsule and preparation thereof |
| 04/08/2009 | CN101401798A Proanthocyanidin effervescent tablet and preparation method thereof |
| 04/08/2009 | CN101401797A Effervescent tablet containing imatinib mesylate and preparation method thereof |
| 04/08/2009 | CN101401796A Pramipexole orally disintegrating tablets and preparation method thereof |
| 04/08/2009 | CN101401795A Imatinib mesylate orally disintegrating tablets and preparation method thereof |
| 04/08/2009 | CN101401794A Imatinib mesylate chewable tablet and preparation method thereof |
| 04/08/2009 | CN101401792A Method for preparing nanocapsule and nanocapsule composite microsphere |
| 04/08/2009 | CN101401791A Timolol liposome and preparation method thereof |
| 04/08/2009 | CN101401790A Lavo-ofloxacin liposome and preparation method thereof |
| 04/08/2009 | CN101401789A Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 04/08/2009 | CN101401788A Self-emulsifying formulation of biphenyldicarboxylate and preparation method thereof |
| 04/08/2009 | CN101401787A Ceftiofur long-acting injection and preparation method thereof |
| 04/08/2009 | CN101401786A Nelarabine injection |
| 04/08/2009 | CN101401785A Amino acid injection and preparation method thereof |
| 04/08/2009 | CN101401784A Sodium closantel injection formulation and preparation method thereof |
| 04/08/2009 | CN101401783A Percutaneous absorption agent containing Ailamode, preparation method and medical uses thereof |
| 04/08/2009 | CN101401782A Doractin dashing agent and method of preparing the same |
| 04/08/2009 | CN100475960C Method for the recombination of genetic elements |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475850C Grain fractionation methods and products |
| 04/08/2009 | CN100475835C 23-Hydroxyl betulinic acid kind derivant and preparing process, preparation and use thereof |
| 04/08/2009 | CN100475829C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/08/2009 | CN100475825C Acyclic nucleoside phosphonate derivatives |
| 04/08/2009 | CN100475824C Novel phosphonic acid compounds as inhibitors of serine proteases |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475819C Pseudopolymorphic forms of a HIV protease inhibitor |
| 04/08/2009 | CN100475817C Crystal of 1-methyl carbapenem compound |
| 04/08/2009 | CN100475816C Reverse-turn mimetics and method relating thereto |
| 04/08/2009 | CN100475815C HIV-reproduction-inhibitive purinderivater |
| 04/08/2009 | CN100475814C 7-azaindoles and use thereof as therapeutic agents |
| 04/08/2009 | CN100475813C 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor |
| 04/08/2009 | CN100475812C Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 04/08/2009 | CN100475810C Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
| 04/08/2009 | CN100475804C Isochromanone 4 derivate, preparation process and therapeutic use thereof |
| 04/08/2009 | CN100475796C Thiazole derivatives as cannabinoid receptor modulators |
| 04/08/2009 | CN100475795C Heterocyclic compounds useful as nurr-1 activators |
| 04/08/2009 | CN100475793C Quinazoline derivatives and use for preparing medicine |
| 04/08/2009 | CN100475792C Novel gamma-secretase inhibitors |
| 04/08/2009 | CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 04/08/2009 | CN100475781C Androgen receptor modulators |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2009 | CN100475775C Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 04/08/2009 | CN100475757C Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome |
| 04/08/2009 | CN100475753C Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion |
| 04/08/2009 | CN100475363C Sugar binding surface |
| 04/08/2009 | CN100475269C Binding agent of hydrophilic polymer-glutamic acid oligopeptide and medicinal molecular, composition containing said binding agent and use thereof |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475253C Medicine for treating barrenness, irregular menses, painful menstruation, endocrine dyscrasia and osteoporosis |
| 04/08/2009 | CN100475245C Medicine used for reducing weight, regulating fat metabolism and reducing blood fat |
| 04/08/2009 | CN100475233C Combination of Chinese traditional medicine for treating angina pectoris as well as preparation method and usage |
| 04/08/2009 | CN100475231C Black soybean polysaccharides |
| 04/08/2009 | CN100475230C Method for preparing medicine treating burn and scald with water melon peel |
| 04/08/2009 | CN100475223C Medicament box used for treating acute anhelation syndrome |
| 04/08/2009 | CN100475221C A composition (RCUD) for protecting and/or repairing DNA from oxidative damages and a method thereof |
| 04/08/2009 | CN100475220C Medicine for treating cardiocerebral vascular disease and preparing method thereof |
| 04/08/2009 | CN100475219C Use of liposoluble stilbene glycoside kind compound in treating ischemic heart brain blood vessel disease and preparation thereof |
| 04/08/2009 | CN100475218C Blattbulume extract, prepn process and application thereof |
| 04/08/2009 | CN100475217C Use of Ocotillol in preparing a drug-dropping and intelligence-promoting medicine |
| 04/08/2009 | CN100475216C Compound lycopene formulation for women and preparation process thererof |
| 04/08/2009 | CN100475215C Cefuroxime axetil taste masking pellet and method of preparing the same |
| 04/08/2009 | CN100475214C Medicine composite contg. Moxabilli and antioxidant |
| 04/08/2009 | CN100475213C Composition of an external dermatological agent and fibers with effect of promoting lipid decomposition |
| 04/08/2009 | CN100475212C Combination of a nitrogen mustard analogue and imatinib mesylate for the treatment of chronic lymphocytic leukemia |
| 04/08/2009 | CN100475211C Oral itraconazole composition being not affected by ingested food and process for preparing same |
| 04/08/2009 | CN100475210C Modified release multiple-units dosage composition |
| 04/08/2009 | CN100475209C Anti-coronavirus drug |
| 04/08/2009 | CN100475208C Hyperlipemia therapeutic agent |
| 04/08/2009 | CN100475207C 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 04/08/2009 | CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/08/2009 | CN100475205C Use of AR-A014418 in preparing medicine for preventing and treating nerve degenerative diseases |
| 04/08/2009 | CN100475204C Pilocarpine nitrate dispersible tablet and preparation method thereof |
| 04/08/2009 | CN100475203C Preparing method of triptolide molecule microcapsule |
| 04/08/2009 | CN100475202C Medicinal composition with function of clearing away heat and toxic material |
| 04/08/2009 | CN100475201C Preparing method of slow released diacetyl rheinic acid tablet |
| 04/08/2009 | CN100475200C Popofol oral anesthesia agent and preparation method thereof |
| 04/08/2009 | CN100475199C Synergistic combinations of macrolide T-cell modulator or inmunosuppressant and a retinoid |
| 04/08/2009 | CN100475197C Oral sustained release pharmaceutical composition |
| 04/08/2009 | CN100475195C Micro-pills of Niuhuang Shangqing Wan Contg. calculus Bovis, and prepn. method thereof |
| 04/08/2009 | CN100475190C Implantation slow release medicine in eyes |
| 04/08/2009 | CN100475061C Combinations of vasoprotective agents and formulations containing the agents |
| 04/08/2009 | CN100475060C Physiologically functional foods or cosmetics containing sphingoglycolipids and processes for their production |
| 04/07/2009 | US7514595 Targeted and regional cellular ablation in zebrafish |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514582 Cardiac ANTIARRHYTHMIA AGENTS; atrial fibrillation or atrial flutter; Kv1.5 potassium channel blockers; |
| 04/07/2009 | US7514574 Biodegradable penetration enhancers with multiple hydrophilic moieties |
| 04/07/2009 | US7514572 Spiro ortho ester-ether-substituted furocoumarins derived from citrus fruits, especially grapefruit; nontoxic |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | US7514567 Oxazolidinone nicotinic acetylcholine receptor agonists |